Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB1 | P15086 | 1/20 | 0.51 |
| ▸ | CNR2 | P34972 | 2/20 | 0.49 |
| ▸ | CNR1 | P21554 | 1/20 | 0.49 |
| ▸ | NR1H4 | Q96RI1 | 11/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | TSPO | P30536 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2157556 | 0.92 | CPB1 (0.59) | CPB1NR1H4HTTCYP3A4MEN1 | |
| SCHEMBL12464648 | 0.90 | CPB1 (0.52) | CPB1CNR2CNR1NR1H4HTT | |
| SCHEMBL12464574 | 0.88 | NR1H4 (0.49) | CPB1NR1H4HTTCYP3A4MEN1 | |
| SCHEMBL2157810 | 0.87 | CPB1 (0.57) | CPB1CNR2CNR1NR1H4HTT | |
| SCHEMBL12464234 | 0.86 | CPB1 (0.48) | CPB1NR1H4HTTCYP3A4MEN1 | |
| SCHEMBL12464387 | 0.86 | CNR2 (0.51) | CPB1CNR2CNR1NR1H4HTT | |
| SCHEMBL2158851 | 0.85 | LTB4R2 (0.48) | CNR2HTTMEN1KMT2AALDH1A1 | |
| SCHEMBL12464430 | 0.82 | CPB1 (0.47) | CPB1CNR2CNR1NR1H4LMNA | |
| SCHEMBL12464650 | 0.82 | NR1H4 (0.50) | CNR2NR1H4HTTMEN1KMT2A | |
| SCHEMBL2157917 | 0.79 | HTT (0.43) | CPB1CNR2CNR1NR1H4HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7985769-B2 | Compounds and methods for the treatment or prevention of Flavivirus infections | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2011-07-26 | — | — | US | disclosed |